EP0881884A4 - Systeme d'apport bacterien - Google Patents

Systeme d'apport bacterien

Info

Publication number
EP0881884A4
EP0881884A4 EP96932169A EP96932169A EP0881884A4 EP 0881884 A4 EP0881884 A4 EP 0881884A4 EP 96932169 A EP96932169 A EP 96932169A EP 96932169 A EP96932169 A EP 96932169A EP 0881884 A4 EP0881884 A4 EP 0881884A4
Authority
EP
European Patent Office
Prior art keywords
delivery system
bacterial delivery
bacterial
delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96932169A
Other languages
German (de)
English (en)
Other versions
EP0881884A1 (fr
Inventor
Arthur A Branstrom
Donata R Sizemore
Jerald C Sadoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Army
Original Assignee
US Department of Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/523,855 external-priority patent/US5824538A/en
Application filed by US Department of Army filed Critical US Department of Army
Publication of EP0881884A1 publication Critical patent/EP0881884A1/fr
Publication of EP0881884A4 publication Critical patent/EP0881884A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP96932169A 1995-09-06 1996-09-06 Systeme d'apport bacterien Withdrawn EP0881884A4 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US331895P 1995-09-06 1995-09-06
US3318 1995-09-06
US08/523,855 US5824538A (en) 1995-09-06 1995-09-06 Shigella vector for delivering DNA to a mammalian cell
US523855 1995-09-06
US1803596P 1996-05-21 1996-05-21
US18035 1996-05-21
PCT/US1996/014190 WO1997008955A1 (fr) 1995-09-06 1996-09-06 Systeme d'apport bacterien

Publications (2)

Publication Number Publication Date
EP0881884A1 EP0881884A1 (fr) 1998-12-09
EP0881884A4 true EP0881884A4 (fr) 2004-07-14

Family

ID=27357382

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96932169A Withdrawn EP0881884A4 (fr) 1995-09-06 1996-09-06 Systeme d'apport bacterien

Country Status (6)

Country Link
EP (1) EP0881884A4 (fr)
JP (1) JP2000500734A (fr)
AU (1) AU731061B2 (fr)
CA (1) CA2231332C (fr)
IL (1) IL123569A (fr)
WO (1) WO1997008955A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998048026A1 (fr) * 1997-04-18 1998-10-29 Gesellschaft für Biotechnologische Forschung mbH Souche attenuee de salmonella utilisee en tant que vehicule d'immunisation orale
IL134936A0 (en) 1997-09-10 2001-05-20 Vion Pharmaceuticals Inc Genetically modified tumor-targeted bacteria with reduced virulence
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
US6368604B1 (en) 1997-09-26 2002-04-09 University Of Maryland Biotechnology Institute Non-pyrogenic derivatives of lipid A
AU750106B2 (en) * 1997-10-07 2002-07-11 University Of Maryland Biotechnology Institute Method for introducing and expressing RNA in animal cells
DE19754938B4 (de) * 1997-12-11 2006-04-20 Christoph von Dr. Eichel-Streiber TGC-Verfahren zur Induktion einer zielgerichteten, somatischen Transgenität
US6825028B1 (en) * 1998-12-11 2004-11-30 Christoph Von Eichel-Streiber Recombinant listeria
US6143551A (en) * 1997-12-29 2000-11-07 Schering Aktiengesellschaft Delivery of polypeptide-encoding plasmid DNA into the cytosol of macrophages by attenuated listeria suicide bacteria
CU22661A1 (es) * 1997-12-30 2001-04-27 Cnic Ct Nac Investigaciones Nuevos candidatos vacunales de vibrio cholerae y método de obtención
US6596477B1 (en) 1998-09-28 2003-07-22 University Of Maryland Biotechnology Institute Treatment and prevention of immunodeficiency virus infection by administration of non-pyrogenic derivatives of lipid A
BR0014491A (pt) * 1999-10-04 2004-03-09 Vion Pharmaceuticals Inc Bactérias atenuadas marcadas para tumor, composição farmacêutica, uso de bactérias atenuadas, e, proteina de fusão
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
US8053568B2 (en) * 2004-11-30 2011-11-08 Aeras Global Tb Vaccine Foundation Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof
KR100967868B1 (ko) * 2004-12-17 2010-07-05 베쓰 이스라엘 디코니스 메디칼 센터 박테리아 매개 유전자 침묵을 위한 조성물 및 이것을이용하는 방법
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0351322A1 (fr) * 1988-07-15 1990-01-17 Institut Pasteur Shigella transformée

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077044A (en) * 1980-05-19 1991-12-31 The Board Of Trustees Of The Leland Stanford Jr. University Novel non-reverting shigella live vaccines
US4632830A (en) * 1981-07-31 1986-12-30 The United States Of America As Represented By The Secretary Of The Army Oral vaccine for immunization against enteric disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0351322A1 (fr) * 1988-07-15 1990-01-17 Institut Pasteur Shigella transformée

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
HIGH N ET AL: "IpaB of Shigella flexneri causes entry into epithelial cells and escape from the phagocytic vacuole.", THE EMBO JOURNAL. MAY 1992, vol. 11, no. 5, May 1992 (1992-05-01), pages 1991 - 1999, XP000999368, ISSN: 0261-4189 *
LINDBERG A A ET AL: "Development of an auxotrophic oral live Shigella flexneri vaccine.", VACCINE. APR 1988, vol. 6, no. 2, April 1988 (1988-04-01), pages 146 - 150, XP002280511, ISSN: 0264-410X *
MILLS S D ET AL: "ANALYSIS AND GENETIC MANIPULATION OF SHIGELLA VIRULENCE DETERMINANTS FOR VACCINE DEVELOPMENT", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, vol. 6, no. 2, 1 April 1988 (1988-04-01), pages 116 - 122, XP000051289, ISSN: 0264-410X *
PHALIPON A ET AL: "Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.", BIOLOGICALS : JOURNAL OF THE INTERNATIONAL ASSOCIATION OF BIOLOGICAL STANDARDIZATION. JUN 1995, vol. 23, no. 2, June 1995 (1995-06-01), pages 125 - 134, XP002280510, ISSN: 1045-1056 *
See also references of WO9708955A1 *
SIZEMORE D R ET AL: "Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization.", SCIENCE. 13 OCT 1995, vol. 270, no. 5234, 13 October 1995 (1995-10-13), pages 299 - 302, XP002071287, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
JP2000500734A (ja) 2000-01-25
AU731061B2 (en) 2001-03-22
CA2231332A1 (fr) 1997-03-13
EP0881884A1 (fr) 1998-12-09
CA2231332C (fr) 2007-04-17
AU7105996A (en) 1997-03-27
IL123569A (en) 2006-10-05
WO1997008955A1 (fr) 1997-03-13
IL123569A0 (en) 1998-10-30

Similar Documents

Publication Publication Date Title
SG42768A1 (en) Conveying system
AU5441496A (en) Fluid Delivery System
AU4129396A (en) Diketopiperazine-based delivery systems
ZA96983B (en) Intake system
AU2816297A (en) Recipient-dosage delivery system
DE69626296D1 (en) Digitales breitband-crossconnect system
GB2320742B (en) Aeration system
EP0861399A4 (fr) Systeme d'obturation pour tuyaux
IL124818A0 (en) Telecomunication system
EP0881884A4 (fr) Systeme d'apport bacterien
AU6488596A (en) Comprehensive product delivery system
HUP9602112A3 (en) Gas delivery system
GB9802841D0 (en) Refulling system
GB2315475B (en) Modular engine delivery system
GB9615042D0 (en) Pumping system
EP1011508A4 (fr) Systeme d'apport de constituants
GB9617607D0 (en) Infusate delivery system
GB2301091B (en) Conveyor system
AU5281796A (en) Yarn delivery system
AU3152495A (en) Improved effervescent delivery system
GB9514082D0 (en) Delivery system
GB9518054D0 (en) Delivery system
AU6463596A (en) Delivery system
AU3851195A (en) Delivery system
GB9612466D0 (en) Delivery system

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980326

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20040601

17Q First examination report despatched

Effective date: 20061227

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070508